Resources

This Target Product Profile (TPP) outlines the specifications for a multimodal pulse oximeter - a noninvasive device designed to measure oxygen saturation, pulse rate, respiratory rate, and additional clinical parameters such as temperature, hemoglobin, and blood pressure.The TPP includes detailed guidance on product use, performance characteristics, design considerations, cost expectations, and channels to market. It also incorporates feedback from a global consensus survey, as well as insights from discussions with manufacturers and national stakeholders in Kenya, Senegal, and Tanzania.Additional resources:Advancing next-generation pulse oximeters and AI-assisted health toolsTechnology and Market Landscape (developed by PATH and Unitaid, 2022)Tools for Integrated Management of Childhood Illness project

As digital tools increasingly shape how health services are delivered, community health workers (CHWs) must be equipped with the foundational skills to navigate this new reality. This report presents a comprehensive framework for digital literacy designed specifically for CHWs working in low- and middle-income settings.Grounded in extensive consultations across Africa, the framework outlines:Three levels of digital proficiency (foundational, intermediate, advanced)Seven core competency areas, from device operations to interpersonal communicationCross-cutting skills like AI awareness, problem-solving, and data governanceThis framework is a practical guide for policymakers, implementing partners, and digital health advocates to strengthen CHW capacity and close the digital gender gap.

Digital health transformation starts with people. This curriculum offers a structured, hands-on training program to build the digital literacy of community health workers, aligned with the foundational framework developed by Digital Square.The curriculum includes:8 practical modules, from basic device use to digital financial transactionsReady-to-use learning activities for trainersGuidance for in-person, online, or blended deliveryEmphasis on ethical digital use and cybersecurityCreated with input from frontline workers and ministry partners, this curriculum ensures CHWs are digitally empowered to support their communities with confidence and professionalism.

The Pandemic Fund—hosted by the World Bank—was created in September 2022 to provide a dedicated stream of additional, long-term funding for critical pandemic prevention, preparedness, and response (PPPR) in eligible low- and middle-income countries.According to expert forecasts, there is a 66 percent chance of another COVID-like respiratory pandemic with a death toll of more than 10 million in the next 25 years. To prepare, countries must strengthen their health systems to identify, diagnose, and treat respiratory infections.Tools like pulse oximeters, which detect hypoxemia (low oxygen saturation in the blood), can provide critical data that a respiratory pandemic is emerging, and medical oxygen and related therapies are essential to treatment as the recent COVID-19 pandemic demonstrated. An adequate supply of clinical and biomedical engineers, and technicians trained to operate and maintain both is a critical plank of PPPR.This fact sheet outlines key information and resources for pursuing funding for medical oxygen and pulse oximetry through the Pandemic Fund. It is intended for use by beneficiaries, partners, civil society, and others, in developing funding requests and/or advocating for prioritizing medical oxygen and pulse oximetry in Pandemic Fund proposals.

Artemisinin-based combination therapies (ACTs) are the most effective treatment for Plasmodium falciparum infections—the deadliest form of malaria responsible for the vast majority of the estimated 608,000 malaria deaths reported in 2022.Malaria commodities funders have been hearing about drastic fluctuations in artemisinin prices. This could pose challenges for ACT manufacturers to plan for production costs and ensure stable, affordable prices.Currently, key global health stakeholders lack a comprehensive understanding of the Chinese artemisinin market structure and dynamics, which limits insights into the price drivers of vegetal artemisinin.PATH produced this 3-month market landscape to enable the global health community to better understand the Chinese artemisinin market and current price fluctuations and to inform efforts to ensure sufficient and affordable access to ACTs.